封面
市场调查报告书
商品编码
1738325

法医基因组学市场-全球产业规模、份额、趋势、机会和预测(按组件、技术、应用、地区和竞争细分,2020-2030 年)

Forensic Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Technique, By Application, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球法医基因组学市场价值为 5.8715 亿美元,预计到 2030 年将达到 13.4726 亿美元,预测期内的复合年增长率为 14.85%。由于政府和私营部门增加对具有成本效益的法医检测技术的资金投入,市场正在经历显着扩张。这包括全球国营法医实验室分析物证的能力增强。日益增长的安全问题,尤其是在国际和国内机场,再加上犯罪活动的日益猖獗,进一步刺激了对先进法医解决方案的需求。在法医科学进步的推动下,法医部门采用尖端设备也提高了调查效率。此外,执法机构越来越依赖基因组技术来破案,也推动了市场成长。值得注意的是,华盛顿大学和美国国土安全部于 2022 年利用 DNA 追踪象牙走私网络的合作研究,体现了法医基因组学在全球安全行动中日益扩大的作用。

市场概览
预测期 2026-2030
2024年市场规模 5.8715亿美元
2030年市场规模 13.4726亿美元
2025-2030 年复合年增长率 14.85%
成长最快的领域 软体
最大的市场 北美洲

关键市场驱动因素

犯罪率上升,对先进法医解决方案的需求增加

主要市场挑战

道德问题和资料隐私问题

主要市场趋势

法医基因组学中人工智慧和机器学习的整合

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球法医基因体学市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按组件(试剂盒、分析仪和定序仪、软体、耗材)
    • 依技术(毛细管电泳 {CE}、次世代定序 {NGS}、PCR 扩增)
    • 按应用(犯罪测试、亲子鑑定和家庭测试、生物防御、其他)
    • 按地区
    • 按公司分类(2024)
  • 市场地图
    • 按组件
    • 依技术
    • 按应用
    • 按地区

第六章:北美法医基因体学市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲法医基因体学市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太法医基因体学市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美洲法医基因组学市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东和非洲法医基因组学市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 併购
  • 产品发布

第 13 章:全球法医基因组学市场:SWOT 分析

第 14 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品/服务的威胁

第 15 章:竞争格局

  • Illumina, Inc.
  • Verogen, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fischer Scientific, Inc.
  • QIAGEN NV
  • GE Healthcare
  • Gene by Gene, Ltd.
  • Neogen Corporation
  • Eurofins Scientific SE
  • Othram Inc.

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 14429

The Global Forensic Genomics Market was valued at USD 587.15 million in 2024 and is projected to reach USD 1347.26 million by 2030, growing at a CAGR of 14.85% during the forecast period. The market is experiencing notable expansion, driven by increased funding from both governmental and private sectors for cost-efficient forensic testing technologies. This includes enhanced capabilities for analyzing physical evidence in state-run forensic labs globally. Rising security concerns, especially at international and domestic airports, coupled with the growing prevalence of criminal activities, are further fueling demand for advanced forensic solutions. The adoption of cutting-edge equipment in forensic departments, bolstered by advancements in forensic science, is also enhancing investigative efficiency. Additionally, law enforcement agencies' growing reliance on genomic technologies to solve crimes is propelling market growth. Notably, collaborative research, such as the 2022 initiative by the University of Washington and U.S. Department of Homeland Security using DNA to trace ivory smuggling networks, exemplifies the expanding role of forensic genomics in global security operations.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 587.15 Million
Market Size 2030USD 1347.26 Million
CAGR 2025-203014.85%
Fastest Growing SegmentSoftware
Largest MarketNorth America

Key Market Drivers

Increasing Crime Rates and Demand for Advanced Forensic Solutions

The rise in violent crime globally is a key factor propelling the forensic genomics market, as law enforcement agencies turn to precise, advanced tools to improve investigative outcomes. Forensic genomics offers highly accurate DNA-based identification techniques crucial for solving complex cases. For instance, the FBI reported more than 1.3 million violent crimes in the U.S. in 2022. DNA technology has already been instrumental in resolving over 50,000 cases from 2010 to 2020, according to the U.S. Department of Justice. These figures underline the growing reliance on genomic analysis for cold cases and active investigations, reinforcing the demand for innovative and reliable forensic tools.

Key Market Challenges

Ethical Concerns and Data Privacy Issues

Despite its benefits, forensic genomics raises substantial ethical and data privacy concerns that hinder broader adoption. The practice of collecting and storing DNA-sometimes without clear consent-raises issues around individual rights and potential misuse. For example, collecting genetic material from suspects or their relatives can lead to questions about voluntary participation. Long-term storage of genetic profiles in national databases has sparked fears of surveillance and genetic discrimination. Regulatory bodies like the EU's GDPR impose strict controls on genetic data handling, while advocacy groups such as the ACLU and EFF have voiced concerns about the absence of comprehensive legal safeguards, especially in countries like the United States. These ethical dilemmas could limit public acceptance and regulatory flexibility.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in Forensic Genomics

Artificial intelligence and machine learning are increasingly being integrated into forensic genomics to manage and analyze complex genomic data. AI-driven tools help streamline the interpretation of genetic information by identifying patterns and resolving DNA mixtures from multiple contributors-an essential capability in forensic investigations. Machine learning also enhances phenotypic prediction, enabling law enforcement to deduce physical traits from DNA when suspect databases offer no direct matches. These innovations increase accuracy, reduce turnaround times, and support real-time decision-making in active cases, signaling a technological shift toward automated and scalable forensic solutions.

Key Market Players

  • Illumina, Inc.
  • Verogen, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fischer Scientific, Inc.
  • QIAGEN N.V.
  • GE Healthcare
  • Gene by Gene, Ltd.
  • Neogen Corporation
  • Eurofins Scientific SE
  • Othram Inc.

Report Scope:

In this report, the Global Forensic Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Forensic Genomics Market, By Component:

  • Kits
  • Analyzers & Sequencers
  • Software
  • Consumables

Forensic Genomics Market, By Technique:

  • Capillary Electrophoresis (CE)
  • Next-generation Sequencing (NGS)
  • PCR Amplification

Forensic Genomics Market, By Application:

  • Criminal Testing
  • Paternity & Familial Testing
  • Biodefense
  • Others

Forensic Genomics Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Forensic Genomics Market.

Available Customizations:

Global Forensic Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Forensic Genomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Kits, Analyzers & Sequencers, Software, Consumables)
    • 5.2.2. By Technique (Capillary Electrophoresis {CE}, Next-generation Sequencing {NGS}, PCR Amplification)
    • 5.2.3. By Application (Criminal Testing, Paternity & Familial Testing, Biodefense, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Technique
    • 5.3.3. By Application
    • 5.3.4. By Region

6. North America Forensic Genomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Forensic Genomics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Forensic Genomics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Forensic Genomics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application

7. Europe Forensic Genomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Forensic Genomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Forensic Genomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Forensic Genomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Forensic Genomics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Forensic Genomics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application

8. Asia-Pacific Forensic Genomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Forensic Genomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
    • 8.3.2. India Forensic Genomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Forensic Genomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Forensic Genomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Forensic Genomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application

9. South America Forensic Genomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Forensic Genomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Forensic Genomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Forensic Genomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application

10. Middle East and Africa Forensic Genomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Forensic Genomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Forensic Genomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Forensic Genomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Forensic Genomics Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

  • 15.1. Illumina, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Verogen, Inc.
  • 15.3. Agilent Technologies, Inc.
  • 15.4. Thermo Fischer Scientific, Inc.
  • 15.5. QIAGEN N.V.
  • 15.6. GE Healthcare
  • 15.7. Gene by Gene, Ltd.
  • 15.8. Neogen Corporation
  • 15.9. Eurofins Scientific SE
  • 15.10. Othram Inc.

16. Strategic Recommendations

17. About Us & Disclaimer